Following on from a previous letter sent by NHS England, Public Health England and the Department of Health and Social Care, NHS England has today (23rd January) published an update on vaccines for the 2019/20 Flu Vaccination Service.
As stated in the previous letter, the vaccinesrecommended for the 2018/19 season continue to be recommended for the 2019/20 season. Both are currently licensed and available to order for use in the United Kingdom:
NHS England has determined that the high-dose trivalent vaccine (TIV-HD), which has also been granted licensed status, has a significantly higher list price and will therefore not be commissioned by NHS England or reimbursed for use in the Flu Vaccination Service 2019/20. Contractors are therefore advised not to purchase or administer this product for the Advanced Flu Vaccination Service. A summary table detailing indicative age groups, licensure status and NHS cost per dose is included as an annex in the letter. Click here to view the letter
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
Copies of our older Paper Based News Letters (The LPC News) can be found by clicking below.
Categories
All
|